June 07, 2022/IndustryNewsGlobal/ The unexpected shifts in the global markets because of the sudden outbreak of the COVID-19 virus have brought many major and minor tremors to industries of all sizes including the In Vitro Diagnostics Market.
It was estimated prior to this unanticipated outbreak that the In Vitro Diagnostics Market is likely to witness an impressive CAGR of 5.0% during 2022-2027. Major factors such as the high prevalence of chronic and infectious diseases, the rapid development of diagnostic kits for the diagnosis of COVID-19 by key companies, and the growing demand for IVD kits and reagents are likely to propel the growth of the in vitro diagnostics market during the forecast period.
Market Scope & Segmentation
In vitro diagnostics are tests which are performed on blood samples or tissues that have been taken from the human body, in order to detect, treat, and prevent diseases.
This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.
For a more detailed breakdown of the COVID-19 impact on the In Vitro Diagnostics Market, request a free sample of the report here:
Market Segments' Analysis
By Product Type
Based on the product type, the market is segmented as instruments, reagents, and others. Reagents are estimated to hold the largest share of the market during the forecast period on account of the increasing need for reagents to meet the growing demand for diagnostics across the world, for the diagnosis of COVID-19 infection.
In terms of regions, North America is estimated to be the dominating region in the market over the forecast period on account of its well-established healthcare industry, rising prevalence of chronic diseases in the region, presence of some of the market's major players, and increasing number of product launches. Europe and Asia-Pacific are also expected to offer substantial growth opportunities during the forecast period.
Key players operating in the global In Vitro Diagnostics market are-
- Abbott Laboratories
- Arkray Inc.
- Becton, Dickinson and Company
- Biomerieux SA
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- F. Hoffmann-La Roche Ltd.
- Siemens Healthcare GmbH
- Sysmex Corporation
- Thermo Fischer Scientific Inc.
Features of the Report
This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools.
The In Vitro Diagnostics analysis report discusses the following heads in great detail:
- Market structure: Overview, industry life cycle analysis, supply chain analysis
- COVID-19 Impact Assessment
- Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
- Market trend and forecast analysis
- Market segment trend and forecast
- Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
- Attractive market segments and associated growth opportunities
- Emerging trends
- Strategic growth opportunities for the existing and new players
- Key success factors
Know more about Stratview Research:
Stratview Research is a global market research company and is known to offer custom research reports in varied fields such as aerospace & Defense, Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas. Our team makes sure to have deep research about the topics so that the most useful insights can be delivered to the professionals.
Need a detailed report? Get in touch with us: